Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910934 · ClinicalTrials.gov registry record · NA
Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique
A NA study, sponsored by PATH.
- Completed
- Registry status
- NA
- Development phase
- 3,915
- Enrollment target
NCT02910934 is a NA study that has completed, run by PATH. The registered enrollment target is 3,915 participants.
The verdict
NCT02910934, a NA study, has completed, sponsored by PATH.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,915 participants
- Enrollment target
Study Summary
This study aims to provide National Malaria Control Programs (NMCP), international donors and other key stakeholders with clear evidence on the impact and cost-effectiveness of using indoor residual spraying (IRS) with a non-pyrethroid insecticide in a high malaria transmission area that has universal long-lasting insecticidal net (LLIN) coverage. This is an interventional study with IRS serving as the research intervention. The district of Mopeia, in the province of Zambezia, Mozambique will be the study site. This is a high transmission area with a malaria parasite prevalence of 54% in children. The Ministry of Health distributed LLINs in Mopeia in 2014-2015. The NMCP through funding from President's Malaria Initiative Africa Indoor Residual Spraying Project (PMI-AIRS) was able to cover half a district with indoor residual spraying. A simplified census took place in mid-2016 to determine the number of children five years of age and under in the district and enumerate and map the households to assist in implementation. From the 115 villages/bairros existent in Mopeia, 86 clusters were randomized in a government randomization ceremony to either receive IRS with Actellic or maintain no IRS. The IRS was implemented through a partnership between the NMCP and PMI-AIRS according to standard operational and consent procedures. From each cluster, a cohort of 18 children five years of age and under will be followed monthly to assess malaria incidence at the community level in both IRS and non-IRS villages. There will be 774 children in the IRS villages and 774 children in the no-IRS villages (total cohort will be 1548). Additionally, the routine health centre reporting system will be strengthened to assess malaria incidence in children five years of age and under by passive case detection. Three cross sectional studies in April 2017, April 2018, and April 2019 will assess changes in net use, health seeking behaviour and malaria prevalence at the community level. Entomol
Interventions
- OTHER Actellic CS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,915 participants |
| Start Date | 2017-01-10 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02910934
The ClinicalTrials.gov registry entry for NCT02910934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,915 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PATH, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Actellic CS is the first listed.
NCT02910934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02910934 about?
NCT02910934 is a clinical study titled "Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique". This study aims to provide National Malaria Control Programs (NMCP), international donors and other key stakeholders with clear evidence on the impact and cost-effectiveness of using indoor residual spraying (IRS) with a non-pyrethroid insecticide in a high malaria transmission area that has univers...
What is the current status of trial NCT02910934?
This trial is currently completed. It is a NA study. The enrollment target is 3,915 participants. The study started on 2017-01-10. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02910934?
The interventions under investigation include: Actellic CS (OTHER).
Who is sponsoring clinical trial NCT02910934?
This trial is sponsored by PATH, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.